diff --git a/_CV/CV.typ b/_CV/CV.typ index c40e034..af92655 100644 --- a/_CV/CV.typ +++ b/_CV/CV.typ @@ -114,10 +114,7 @@ _Career Awards at the Scientific Interface Finalist_, Burroughs Wellcome Fund #h _Fellowship_, Terri Brodeur Breast Cancer Foundation #h(1fr) 2017 -#link("http://www.amgenscholars.com/alumni/ten-to-watch")[_Ten to Watch_], Amgen Scholars Foundation #h(1fr) 2016 - -_Director's Early Independence Award_, National Institutes of Health #h(1fr) 2014 \ -Highlighted by the NIH director's office (#link("https://directorsblog.nih.gov/2014/10/28/creative-minds-tackling-chemotherapy-resistance/")[link]) +_Director's Early Independence Award_, National Institutes of Health #h(1fr) 2014 _Siebel Scholar, Class of 2014_ #h(1fr) 2013 @@ -253,6 +250,26 @@ _Siebel Scholar, Class of 2014_ #h(1fr) 2013 ] +#section("Media Coverage") + +#link("https://www.youtube.com/watch?v=kobv26lc2Og")[_"UCLA's Aaron Meyer shares about how cancer cells avoid the immune system"_], UCLA Technology Development Group #h(1fr) 2026 \ +Video interview on lab research into anti-tumor antibody responses + +#link("https://www.uclahealth.org/news/publication/ovarian-cancer-hits-below-belt-doctor-raising-army-stop-it")[_"Ovarian cancer hits below the belt: This doctor is raising an army to stop it"_], UCLA Health #h(1fr) 2025 \ +Featured lab research on Fc-mediated immunity in ovarian cancer (with S. Memarzadeh) + +#link("https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/aaron-meyer")[_"Dr. Aaron Meyer: Identifying Combination Therapies for Lung Cancer"_], NCI Cancer Systems Biology Consortium #h(1fr) 2021 \ +Interview on the lab's systems approach to identifying combination therapies for lung cancer + +#link("https://newsroom.ucla.edu/releases/antibody-identifier-could-speed-development-of-therapies-for-cancer-other-diseases")[_"Antibody identifier could speed development of therapies for cancer, other diseases"_], UCLA Newsroom #h(1fr) 2018 \ +Coverage of the lab's antibody effector function model published in Cell Systems + +#link("https://amgenscholars.com/ten-to-watch/")[_"Ten to Watch"_], Amgen Scholars Foundation #h(1fr) 2016 \ +Profile recognizing top Amgen Scholars alumni poised to impact the future of science and medicine + +#link("https://directorsblog.nih.gov/2014/10/28/creative-minds-tackling-chemotherapy-resistance/")[_"Creative Minds: Tackling Chemotherapy Resistance"_], NIH Director's Blog #h(1fr) 2014 \ +Feature on research supported by the Director's Early Independence Award + #section("Research Support") _Contact PI on all grants unless indicated otherwise._ @@ -560,7 +577,7 @@ Massachusetts Institute of Technology #section("Patents & Disclosures") -A.S. Meyer. "Methods of Identifying and Correcting Tumor Humoral Immune Dysregulation." U.S. patent application PCT/US24/32940, 2024. +A.S. Meyer. "Methods of Identifying and Correcting Tumor Humoral Immune Dysregulation." U.S. patent application PCT/US24/32940, 2024; U.S. National Phase Application No. 19/491,103, filed December 8, 2025. Orcutt-Jahns, B., P.C. Emmel, A.S. Meyer. "Multi-specific engineered cytokines." U.S. patent application PCT/US24/32940, 2023. diff --git a/data/service.yaml b/data/service.yaml index d0efb1f..60f5902 100644 --- a/data/service.yaml +++ b/data/service.yaml @@ -246,6 +246,18 @@ service: - role: Ad Hoc Reviewer organization: EMBO Molecular Medicine + date: "2025, 2026" + + - role: Ad Hoc Reviewer + organization: Frontiers in Immunology + date: "2026" + + - role: Ad Hoc Study Section + organization: National Cancer Institute (R21, overflow panel) + date: "2026" + + - role: External Reviewer + organization: The Royal Society date: "2025" - role: Poster Judge diff --git a/data/talks.yaml b/data/talks.yaml index a7b0632..28d9daf 100644 --- a/data/talks.yaml +++ b/data/talks.yaml @@ -1,4 +1,34 @@ presentations: + - venue: USC, Mork Family Department of Chemical Engineering and Materials Science + type: Invited Seminar + date: 2026-11-03 + title: "Building and integrative view of immunity through tensor decompositions" + + - venue: "Signal Transduction by Engineered Extracellular Matrices GRC (Switzerland)" + type: Invited Oral Presentation + date: 2026-06-04 + title: "Deciphering the Inflammatory Milieu: Tracking and Disrupting Tissue-Local Cytokine Regulation" + + - venue: UCLA QCBio Seminar + type: Invited Oral Presentation + date: 2026-07-31 + title: "Building an Integrative View of Immunity with Data Tensors" + + - venue: Amgen Scholars Program North America Symposium + type: Invited Keynote + date: 2026-07-17 + title: "Design Constraints for an Unknown Future" + + - venue: "ASHI/AMLI Joint Member Society Symposium, FOCIS Annual Meeting" + type: Invited Oral Presentation + date: 2026-06-10 + title: "Deciphering the Inflammatory Milieu: Tracking and Disrupting Tissue-Local Cytokine Regulation: Application to Transplantation and Beyond" + + - venue: UCLA, I3T Seminar + type: Invited Seminar + date: 2026-05-01 + title: "Building an integrative understanding of immunity and immune states" + - venue: UCSD, The Bioengineering Experience type: Invited Keynote date: 2026-05-08 diff --git a/data/team.yml b/data/team.yml index fe5e93d..13e1c93 100644 --- a/data/team.yml +++ b/data/team.yml @@ -385,6 +385,7 @@ awards: - SURF Fellowship, UCLA Graduate Division - JCCC Fellowship + - UCLA Bioengineering Department Fellowship - name: Meera Trisal position: Ph.D. Student @@ -540,6 +541,8 @@ joined: 2025 photo: lipika.webp current: True + awards: + - Hu Family BIG Summer Fellowship - name: Maxence Larour-Debonneuil position: Undergraduate Researcher @@ -548,6 +551,8 @@ joined: 2025 photo: mlarour.webp current: True + awards: + - URC-Sciences Summer Program - name: Breanna Remigio position: Undergraduate Researcher